当前位置:首页 - 行情中心 - 汇宇制药-W(688553) - 财务分析 - 现金流量表

汇宇制药-W

(688553)

  

流通市值:60.02亿  总市值:74.00亿
流通股本:3.44亿   总股本:4.24亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金280,233,475.251,115,440,951.67913,898,156.93576,129,500.01
  收到的税费返还5,146,499.7116,575,008.6413,021,236.948,318,146.46
  收到其他与经营活动有关的现金32,865,984.95156,201,919.11104,968,779.2277,654,836.08
  经营活动现金流入小计318,245,959.911,288,217,879.421,031,888,173.09662,102,482.55
  购买商品、接受劳务支付的现金78,097,985.63327,967,913.52279,761,178.2196,853,160.68
  支付给职工以及为职工支付的现金66,613,043.46257,972,487.79167,827,687.64119,755,694.51
  支付的各项税费15,811,158.5537,682,759.4157,162,814.0337,432,550.4
  支付其他与经营活动有关的现金137,557,191.16574,081,272.56495,968,159.94335,126,793.27
  经营活动现金流出小计298,079,378.81,197,704,433.281,000,719,839.81689,168,198.86
  经营活动产生的现金流量净额平衡项目-0.01000
  经营活动产生的现金流量净额20,166,581.190,513,446.1431,168,333.28-27,065,716.31
二、投资活动产生的现金流量:
  收回投资收到的现金70,720,000645,990,532.43580,405,909.78263,000,000
  取得投资收益收到的现金7,584,60441,191,997.23,005,902.032,703,545.94
  处置固定资产、无形资产和其他长期资产收回的现金净额30300,256.6583,789.7920,000
  投资活动现金流入小计78,304,634687,482,786.28583,495,601.6265,723,545.94
  购建固定资产、无形资产和其他长期资产支付的现金13,457,865.81105,273,826.7882,355,562.1851,722,115.35
  投资支付的现金110,000,000450,820,000363,000,000233,000,000
  支付其他与投资活动有关的现金-600,000--
  投资活动现金流出小计123,457,865.81556,693,826.78445,355,562.18284,722,115.35
  投资活动产生的现金流量净额-45,153,231.81130,788,959.5138,140,039.42-18,998,569.41
三、筹资活动产生的现金流量:
  取得借款收到的现金283,900,000493,146,000390,146,000359,146,000
  收到其他与筹资活动有关的现金48,000,000408,000,000234,925,444.45234,925,444.45
  筹资活动现金流入小计331,900,000901,146,000625,071,444.45594,071,444.45
  偿还债务支付的现金185,900,000385,100,000365,004,466.67325,000,000
  分配股利、利润或偿付利息支付的现金2,271,723.58199,070,599.61194,946,780.04193,157,388.37
  支付其他与筹资活动有关的现金59,000,000217,026,470165,639,900165,639,900
  筹资活动现金流出小计247,171,723.58801,197,069.61725,591,146.71683,797,288.37
  筹资活动产生的现金流量净额84,728,276.4299,948,930.39-100,519,702.26-89,725,843.92
四、汇率变动对现金及现金等价物的影响-1,818,039.13-726,383.543,909,781.693,959,643.3
  现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额57,923,586.58320,524,952.4972,698,452.13-131,830,486.35
  加:期初现金及现金等价物余额2,377,769,199.012,057,244,246.522,057,244,246.522,057,244,246.52
  期末现金及现金等价物余额平衡项目00-0.010
  期末现金及现金等价物余额2,435,692,785.592,377,769,199.012,129,942,698.641,925,413,760.17
补充资料:
  净利润--30,547,754.14--83,595,454.15
  资产减值准备-5,406,404.61--102,518.99
  固定资产和投资性房地产折旧-87,435,439.06-44,176,735.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-87,435,439.06-44,176,735.62
  无形资产摊销-2,412,718.17-1,113,421.18
  长期待摊费用摊销-921,763.68-460,881.84
  处置固定资产、无形资产和其他长期资产的损失--1,887.15-21,342.13
  固定资产报废损失-118,576.53--
  公允价值变动损失-167,003,663.92-146,324,714.95
  财务费用-4,206,892.91-5,248,399.9
  投资损失--477,465.87--3,029,759.73
  递延所得税--35,352,039.41--23,488,849.5
  其中:递延所得税资产减少--36,043,845.36--20,563,569.79
    递延所得税负债增加-691,805.95--2,925,279.71
  存货的减少--110,201,879.82--58,215,946.64
  经营性应收项目的减少--41,960,444.74-30,501,313.61
  经营性应付项目的增加-36,123,615.11--88,214,100.98
  其他-1,290,878.57--
  现金的期末余额-2,377,769,199.01-1,925,413,760.17
  减:现金的期初余额-2,057,244,246.52-2,057,244,246.52
  现金及现金等价物的净增加额-320,524,952.49--131,830,486.35
公告日期2026-04-252026-04-252025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑